Cargando…

Prescribing issues in older adults living with HIV: thinking beyond drug–drug interactions with antiretroviral drugs

Detalles Bibliográficos
Autores principales:	Livio, Françoise, Marzolini, Catia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777047/ https://www.ncbi.nlm.nih.gov/pubmed/31620274 http://dx.doi.org/10.1177/2042098619880122

Ejemplares similares

Drug–Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?
por: Bukkems, Vera E., et al.
Publicado: (2020)

Cobicistat: A case of mislabelled drug‐drug interaction risk?
por: Burger, David M., et al.
Publicado: (2020)

Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019)

Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications
por: Stader, Felix, et al.
Publicado: (2018)

Dexamethasone is a dose-dependent perpetrator of drug–drug interactions: implications for use in people living with HIV
por: Jacobs, Tom G, et al.
Publicado: (2021)

Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs
por: Courlet, Perrine, et al.
Publicado: (2021)

Magnitude of Drug–Drug Interactions in Special Populations
por: Bettonte, Sara, et al.
Publicado: (2022)

925. Adverse Events Due to Inappropriate Prescribing in Older Adults Living with HIV
por: Cinquegrani, Mark, et al.
Publicado: (2020)

Prevalence and management of drug–drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study
por: Schlaeppi, C, et al.
Publicado: (2019)

Prevalence of Drug–Drug Interactions with Hormonal Contraceptives and Antiretrovirals in Women Living with HIV
por: McLaughlin, Milena M, et al.
Publicado: (2017)

Physiologically‐Based Pharmacokinetic Modeling to Support the Clinical Management of Drug–Drug Interactions With Bictegravir
por: Stader, Felix, et al.
Publicado: (2021)

Management of HIV/AIDS in older patients–drug/drug interactions and adherence to antiretroviral therapy
por: Burgess, Mary J, et al.
Publicado: (2015)

Influence of Drug–Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV
por: Courlet, Perrine, et al.
Publicado: (2020)

Clinically significant drug interactions between antiretroviral and co-prescribed drugs in HIV infected patients: retrospective cohort study
por: Al Sayed, Hawra Ali Hussain, et al.
Publicado: (2022)

Potential risk of drug–drug interactions with hormonal contraceptives and antiretrovirals: prevalence in women living with HIV
por: Murray, Milena M, et al.
Publicado: (2020)

Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
por: Hodge, Daryl, et al.
Publicado: (2021)

Evolution of Drug Interactions With Antiretroviral Medication in People With HIV
por: El Moussaoui, Majdouline, et al.
Publicado: (2020)

Special Issue on Drug–Membrane Interactions
por: Pinheiro, Marina
Publicado: (2021)

Impact of Obesity on the Drug–Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers
por: Berton, Mattia, et al.
Publicado: (2023)

Clinically significant interactions between antiretroviral and co-prescribed drugs for HIV-infected children: profiling and comparison of two drug databases
por: Oshikoya, Kazeem A, et al.
Publicado: (2013)

Implications of Bariatric Surgery on the Pharmacokinetics of Antiretrovirals in People Living with HIV
por: Zino, Leena, et al.
Publicado: (2022)

Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19
por: Girardin, François, et al.
Publicado: (2022)

Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain
por: Castro-Granell, Vanessa, et al.
Publicado: (2021)

COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions
por: Back, David, et al.
Publicado: (2020)

Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study
por: Bettonte, Sara, et al.
Publicado: (2022)

Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection
por: Seden, Kay, et al.
Publicado: (2017)

Prescribing opioids and psychotropic drugs in pregnancy
por: Patrick, Stephen W, et al.
Publicado: (2017)

Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study
por: Aebi-Popp, Karoline, et al.
Publicado: (2022)

Special Issue on Drug–Membrane Interactions Volume II
por: Pinheiro, Marina, et al.
Publicado: (2022)

Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions
por: Choi, Min-Koo, et al.
Publicado: (2021)

Antiretroviral drug–drug interactions: A comparison of online drug interaction databases
por: Drwiega, Emily N., et al.
Publicado: (2022)

Potential drug–drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria
por: Oshikoya, Kazeem A, et al.
Publicado: (2014)

Antiretroviral drugs: Critical issues and recent advances
por: Desai, Mira, et al.
Publicado: (2012)

Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders
por: Villoutreix, Bruno O., et al.
Publicado: (2020)

Special Issue “Anticancer Drugs”
por: Meegan, Mary J., et al.
Publicado: (2019)

The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV
por: Rojo, Pablo, et al.
Publicado: (2020)

Development and validation of a multiplex UHPLC‐MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV
por: Courlet, Perrine, et al.
Publicado: (2020)

Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
por: Charpentier, Charlotte, et al.
Publicado: (2023)

Potentially Inappropriate Prescribing and Potential Clinically Significant Drug–Drug Interactions in Older Outpatients: Is There Any Association?
por: Cvetković, Zorica, et al.
Publicado: (2019)

Patient- and Prescriber-Related Factors Associated with Potentially Inappropriate Medications and Drug–Drug Interactions in Older Adults
por: Jang, Suhyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_54lkml15hmakes28kkfq6kqcs1